CHAIR
:
SPEAKER
(S):
Wilfried Loeffler, PhD, Vice President - PET, Siemens Medical Solutions
Raymond Gibson, PhD, Senior Investigator, Merck Research Laboratories
Brian R. Moyer, MS, CNNT, Product Manager, Acute Radiation Syndrome, Dept. of HHS, Officer of Public Health Emergency Countermeasures
Pamela Norton, Principal, IMSHealth
Description
A new generation of imaging agents combined with enhancements in imaging methods and fusion technologies has dramatically improved the ability to visualize molecular, and even cellular, events. This session will survey the landscape of scientific advances and business opportunities and the new challenges these emerging technologies present.
Objectives:
Provide an overview of emerging imaging technologies that are transforming medicine, as well as drug discovery and development.
Understand the strengths and limitations of major imaging modalities.
Explore the business landscape underlying the growth imaging in the development of diagnostics and therapeutics.